European urology最新文献

筛选
英文 中文
Lenvatinib plus Pembrolizumab Following Immune Checkpoint Inhibitor Treatment in Patients with Metastatic Clear Cell Renal Cell Carcinoma: Results from Study 111/KEYNOTE-146 转移性透明细胞肾细胞癌患者接受免疫检查点抑制剂治疗后伦伐替尼加 Pembrolizumab:111/KEYNOTE-146研究结果。
IF 25.3 1区 医学
European urology Pub Date : 2024-11-01 DOI: 10.1016/j.eururo.2024.05.003
Chung-Han Lee , Amishi Yogesh Shah , Arpit Rao , Matthew H. Taylor , Christopher Di Simone , James J. Hsieh , Alvaro Pinto , Regina Gironés Sarrió , Allen Lee Cohn , Mehmet Asim Bilen , Sara Gunnestad Ribe , Øyvind Krohn Tennøe , Donald Richards , Randy F. Sweis , Jay Courtright , Daniel Heinrich , Rodolfo Perini , Peter Kubiak , Daena Bock , Chinyere E. Okpara , Robert J. Motzer
{"title":"Lenvatinib plus Pembrolizumab Following Immune Checkpoint Inhibitor Treatment in Patients with Metastatic Clear Cell Renal Cell Carcinoma: Results from Study 111/KEYNOTE-146","authors":"Chung-Han Lee , Amishi Yogesh Shah , Arpit Rao , Matthew H. Taylor , Christopher Di Simone , James J. Hsieh , Alvaro Pinto , Regina Gironés Sarrió , Allen Lee Cohn , Mehmet Asim Bilen , Sara Gunnestad Ribe , Øyvind Krohn Tennøe , Donald Richards , Randy F. Sweis , Jay Courtright , Daniel Heinrich , Rodolfo Perini , Peter Kubiak , Daena Bock , Chinyere E. Okpara , Robert J. Motzer","doi":"10.1016/j.eururo.2024.05.003","DOIUrl":"10.1016/j.eururo.2024.05.003","url":null,"abstract":"","PeriodicalId":12223,"journal":{"name":"European urology","volume":"86 5","pages":"Pages 470-473"},"PeriodicalIF":25.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141080604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Re: Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool 关于在接受术前前列腺特异性膜抗原正电子发射断层扫描的前列腺癌患者中,通过扩展盆腔淋巴结切除术确定结节分期的最佳候选者。纪念斯隆-凯特琳癌症中心和 Briganti 提名图的外部验证及新工具的开发。
IF 25.3 1区 医学
European urology Pub Date : 2024-11-01 DOI: 10.1016/j.eururo.2024.05.021
Petr Macek, Lara Rodriguez-Sanchez, Xavier Cathelineau
{"title":"Re: Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool","authors":"Petr Macek, Lara Rodriguez-Sanchez, Xavier Cathelineau","doi":"10.1016/j.eururo.2024.05.021","DOIUrl":"10.1016/j.eururo.2024.05.021","url":null,"abstract":"","PeriodicalId":12223,"journal":{"name":"European urology","volume":"86 5","pages":"Pages 478-479"},"PeriodicalIF":25.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141322184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to Kuo-Chin Hung and Chia-Ter Chao’s Letter to the Editor re: Jennifer Kranz, Riccardo Bartoletti, Franck Bruyère, et al. European Association of Urology Guidelines on Urological Infections: Summary of the 2024 Guidelines. Eur Urol. 2024;86:27–41 回复 Kuo-Chin Hung 和 Chia-Ter Chao 致编辑的信,内容涉及:Jennifer Kranz、Riccardo Bartoletti、Franck Bruyère 等人的欧洲泌尿外科协会泌尿系统感染指南:2024 年指南摘要》。Eur Urol.https://doi.org/10.1016/j.eururo.2024.03.035.
IF 25.3 1区 医学
European urology Pub Date : 2024-11-01 DOI: 10.1016/j.eururo.2024.06.021
Jennifer Kranz , Gernot Bonkat
{"title":"Reply to Kuo-Chin Hung and Chia-Ter Chao’s Letter to the Editor re: Jennifer Kranz, Riccardo Bartoletti, Franck Bruyère, et al. European Association of Urology Guidelines on Urological Infections: Summary of the 2024 Guidelines. Eur Urol. 2024;86:27–41","authors":"Jennifer Kranz , Gernot Bonkat","doi":"10.1016/j.eururo.2024.06.021","DOIUrl":"10.1016/j.eururo.2024.06.021","url":null,"abstract":"","PeriodicalId":12223,"journal":{"name":"European urology","volume":"86 5","pages":"Page e116"},"PeriodicalIF":25.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141581891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to Sandra P. García Nader, Cesar A. Díaz Ritter, and Valentina Garcia Perez’s Letter to the Editor re: Carlotta Nedbal, Patrick Juliebø-Jones, Eamonn Rogers, et al. Improving Patient Information and Enhanced Consent in Urology: The Impact of Simulation and Multimedia Tools. A Systematic Literature Review from the European Association of Urology Patient Office. Eur Urol. 2024;86:457–469 对 Sandra P. García Nader、Cesar A. Díaz Ritter 和 Valentina Garcia Perez 致编辑的信的回复,内容涉及:Carlotta Nedbal、Patrick Juliebø-Jones、Eamonn Rogers 等:《改善泌尿外科患者信息和加强同意》:模拟和多媒体工具的影响》。来自欧洲泌尿外科患者办公室协会的系统文献综述》。欧洲泌尿外科》。https://doi.org/10.1016/j.eururo.2024.04.009.
IF 25.3 1区 医学
European urology Pub Date : 2024-11-01 DOI: 10.1016/j.eururo.2024.08.019
Carlotta Nedbal , Bhaskar Kumar Somani
{"title":"Reply to Sandra P. García Nader, Cesar A. Díaz Ritter, and Valentina Garcia Perez’s Letter to the Editor re: Carlotta Nedbal, Patrick Juliebø-Jones, Eamonn Rogers, et al. Improving Patient Information and Enhanced Consent in Urology: The Impact of Simulation and Multimedia Tools. A Systematic Literature Review from the European Association of Urology Patient Office. Eur Urol. 2024;86:457–469","authors":"Carlotta Nedbal , Bhaskar Kumar Somani","doi":"10.1016/j.eururo.2024.08.019","DOIUrl":"10.1016/j.eururo.2024.08.019","url":null,"abstract":"","PeriodicalId":12223,"journal":{"name":"European urology","volume":"86 5","pages":"Pages e124-e125"},"PeriodicalIF":25.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142001598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anti-VEGF and -PD-1 Combinations in Renal Cell Carcinoma: When Are Treatment Breaks Safe? 肾细胞癌中的抗血管内皮生长因子和-PD-1联合疗法:何时中断治疗是安全的?
IF 25.3 1区 医学
European urology Pub Date : 2024-11-01 DOI: 10.1016/j.eururo.2024.06.005
J.C. Wells , Laurence Albiges , Thomas Powles
{"title":"Anti-VEGF and -PD-1 Combinations in Renal Cell Carcinoma: When Are Treatment Breaks Safe?","authors":"J.C. Wells , Laurence Albiges , Thomas Powles","doi":"10.1016/j.eururo.2024.06.005","DOIUrl":"10.1016/j.eururo.2024.06.005","url":null,"abstract":"","PeriodicalId":12223,"journal":{"name":"European urology","volume":"86 5","pages":"Pages 420-421"},"PeriodicalIF":25.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141428530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Re: Transurethral En Bloc Resection Versus Standard Resection of Bladder Tumour: A Randomised, Multicentre, Phase 3 Trial 关于经尿道膀胱肿瘤整体切除术与标准切除术:随机、多中心、3 期试验。
IF 25.3 1区 医学
European urology Pub Date : 2024-11-01 DOI: 10.1016/j.eururo.2024.06.013
Stefano Mancon , Francesco Soria , Benjamin Pradere , David D’Andrea
{"title":"Re: Transurethral En Bloc Resection Versus Standard Resection of Bladder Tumour: A Randomised, Multicentre, Phase 3 Trial","authors":"Stefano Mancon , Francesco Soria , Benjamin Pradere , David D’Andrea","doi":"10.1016/j.eururo.2024.06.013","DOIUrl":"10.1016/j.eururo.2024.06.013","url":null,"abstract":"","PeriodicalId":12223,"journal":{"name":"European urology","volume":"86 5","pages":"Pages 481-482"},"PeriodicalIF":25.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141763482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-world Uptake of Enfortumab Vedotin plus Pembrolizumab after US Food and Drug Administration Approval Among Patients with Advanced Urothelial Cancer 美国食品药品管理局批准 Enfortumab Vedotin 加 Pembrolizumab 用于晚期尿路上皮癌患者后的实际使用情况。
IF 25.3 1区 医学
European urology Pub Date : 2024-11-01 DOI: 10.1016/j.eururo.2024.08.012
Ronac Mamtani , Ernesto Ulloa-Pérez , Ravi B. Parikh , Khilna Patel , Blanca Homet Moreno , Chethan Ramamurthy , Haojie Li , Rebecca A. Hubbard
{"title":"Real-world Uptake of Enfortumab Vedotin plus Pembrolizumab after US Food and Drug Administration Approval Among Patients with Advanced Urothelial Cancer","authors":"Ronac Mamtani , Ernesto Ulloa-Pérez , Ravi B. Parikh , Khilna Patel , Blanca Homet Moreno , Chethan Ramamurthy , Haojie Li , Rebecca A. Hubbard","doi":"10.1016/j.eururo.2024.08.012","DOIUrl":"10.1016/j.eururo.2024.08.012","url":null,"abstract":"","PeriodicalId":12223,"journal":{"name":"European urology","volume":"86 5","pages":"Pages 474-476"},"PeriodicalIF":25.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142038023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Platinum Hall of Fame 白金名人堂
IF 25.3 1区 医学
European urology Pub Date : 2024-11-01 DOI: 10.1016/j.eururo.2024.09.002
{"title":"Platinum Hall of Fame","authors":"","doi":"10.1016/j.eururo.2024.09.002","DOIUrl":"10.1016/j.eururo.2024.09.002","url":null,"abstract":"","PeriodicalId":12223,"journal":{"name":"European urology","volume":"86 5","pages":"Pages e103-e113"},"PeriodicalIF":25.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142599086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role of Microsatellite Instability/DNA Mismatch Repair Deficiency and Tumor Mutational Burden as Biomarkers in Predicting Response to Immunotherapy in Castration-resistant Prostate Cancer 微卫星不稳定性/DNA错配修复缺陷和肿瘤突变负荷作为生物标记物在预测阉割耐药前列腺癌免疫疗法反应中的作用。
IF 25.3 1区 医学
European urology Pub Date : 2024-11-01 DOI: 10.1016/j.eururo.2024.04.026
Niklas Klümper , Viktor Grünwald , Arndt Hartmann , Michael Hölzel , Markus Eckstein
{"title":"The Role of Microsatellite Instability/DNA Mismatch Repair Deficiency and Tumor Mutational Burden as Biomarkers in Predicting Response to Immunotherapy in Castration-resistant Prostate Cancer","authors":"Niklas Klümper , Viktor Grünwald , Arndt Hartmann , Michael Hölzel , Markus Eckstein","doi":"10.1016/j.eururo.2024.04.026","DOIUrl":"10.1016/j.eururo.2024.04.026","url":null,"abstract":"","PeriodicalId":12223,"journal":{"name":"European urology","volume":"86 5","pages":"Pages 388-390"},"PeriodicalIF":25.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140924123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Randomised Trial of No, Short-term, or Long-term Androgen Deprivation Therapy with Postoperative Radiotherapy After Radical Prostatectomy: Results from the Three-way Comparison of RADICALS-HD (NCT00541047) 根治性前列腺切除术后不使用、短期或长期雄激素剥夺疗法配合术后放疗的随机试验:RADICALS-HD的三方比较结果(NCT00541047)。
IF 25.3 1区 医学
European urology Pub Date : 2024-11-01 DOI: 10.1016/j.eururo.2024.07.026
Chris C. Parker , Noel W. Clarke , Adrian D. Cook , Peter M. Petersen , Charles N. Catton , William R. Cross , Howard Kynaston , Raj A. Persad , Fred Saad , John Logue , Heather Payne , Claire Amos , Lorna Bower , Rakesh Raman , Ian Sayers , Jane Worlding , Wendy R. Parulekar , Mahesh K.B. Parmar , Matthew R. Sydes , RADICALS Investigators
{"title":"Randomised Trial of No, Short-term, or Long-term Androgen Deprivation Therapy with Postoperative Radiotherapy After Radical Prostatectomy: Results from the Three-way Comparison of RADICALS-HD (NCT00541047)","authors":"Chris C. Parker ,&nbsp;Noel W. Clarke ,&nbsp;Adrian D. Cook ,&nbsp;Peter M. Petersen ,&nbsp;Charles N. Catton ,&nbsp;William R. Cross ,&nbsp;Howard Kynaston ,&nbsp;Raj A. Persad ,&nbsp;Fred Saad ,&nbsp;John Logue ,&nbsp;Heather Payne ,&nbsp;Claire Amos ,&nbsp;Lorna Bower ,&nbsp;Rakesh Raman ,&nbsp;Ian Sayers ,&nbsp;Jane Worlding ,&nbsp;Wendy R. Parulekar ,&nbsp;Mahesh K.B. Parmar ,&nbsp;Matthew R. Sydes ,&nbsp;RADICALS Investigators","doi":"10.1016/j.eururo.2024.07.026","DOIUrl":"10.1016/j.eururo.2024.07.026","url":null,"abstract":"<div><h3>Background and objective</h3><div>The use and duration of androgen deprivation therapy (ADT) with postoperative radiotherapy (RT) have been uncertain. RADICALS-HD compared adding no (“None”), 6-months (“Short”), or 24-mo (“Long”) ADT to study efficacy in the long term.</div></div><div><h3>Methods</h3><div>Participants with prostate cancer were indicated for postoperative RT and agreed randomisation between all durations. ADT was allocated for 0, 6, or 24 mo. The primary outcome measure (OM) was metastasis-free survival (MFS). The secondary OMs included freedom from distant metastasis, overall survival, and initiation of nonprotocol ADT. Sample size was determined by two-way comparisons. Analyses followed standard time-to-event approaches and intention-to-treat principles.</div></div><div><h3>Key findings and limitations</h3><div>Between 2007 and 2015, 492 participants were randomised one of three groups: 166 None, 164 Short, and 162 Long. The median age at randomisation was 66 yr; Gleason scores at surgery were as follows: &lt;7 = 64 (13%), 3+4 = 229 (47%), 4+3 = 127 (26%), and 8+ = 72 (15%); T3b was 112 (23%); and T4 was 5 (1%). The median follow-up was 9.0 yr and, with MFS events reported for 89 participants (32 None, 31 Short, and 26 Long), there was no evidence of difference in MFS overall (logrank <em>p</em> = 0.98), and, for Long versus None, hazard ratio = 0.948 (95% confidence interval 0.54–1.68). After 10 yr, 80% None, 77% Short, and 81% Long patients were alive without metastatic disease. The three-way randomisation was not powered to conventional levels for assessment, yet provides a fair comparison.</div></div><div><h3>Conclusions and clinical implications</h3><div>Long-term outcomes after radical prostatectomy are usually favourable. In those indicated for postoperative RT and considered suitable for no, short-term, or long-term ADT, there was no evidence of improvement with addition of ADT. Future research should focus on patients at a higher risk of metastases in whom improvements are required more urgently.</div></div>","PeriodicalId":12223,"journal":{"name":"European urology","volume":"86 5","pages":"Pages 422-430"},"PeriodicalIF":25.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142116443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信